Tharakeswara K. Bathala, M.D., M.B.B.S
Department of Abdominal Imaging, Division of Diagnostic Imaging
About Dr. Bathala
Dr. Tharakeswara Bathala is a Professor at the University of Texas MD Anderson Cancer Center. Dr. Bathala joined the faculty at the University of Texas MD Anderson Cancer Center in 2012, after completing his Fellowship in Body Imaging and Interventional Radiology at the Boston University Medical Center. Dr. Bathala is a graduate of the Mysore Medical College, India, graduating with an M.B.B.S. degree in 2002. Followed by a post-graduate education at the Bangalore Medical College, graduating in 2007 with an M.D. in Radiology. Dr. Bathala served as a staff radiologist at the Centerville Medical Pavilion and the Bahamas Cancer Center from September 2007 through July 2009. Dr. Bathala has a dual appointment as adjunct associate professor at school of public health and UT health science center at Houston. He interprets diagnostic images especially ultrasound, CT and MRI scans, and have a special interest in the imaging of patients with genitourinary and gynecological malignancies. He performs ultrasound guided procedures including biopsy, aspiration, intraoperative ultrasound guidance, and sonohysterography.
His research interests include health services research, comparative effectiveness, cancer prevention, and quality improvement. He is the Principal Investigator of a prospective evaluation of metastatic disease and whole-body MR imaging in high risk prostate cancer. He is also the PI of an educational grant that was awarded for the development of curriculum on cancer staging. Dr. Bathala serve as a Collaborator on many novel clinical trials for treatment of advanced malignancies. Dr. Bathala has authored and co-authored multiple articles in peer-reviewed journals. Dr. Bathala is a member of the American Roentgen Ray Society, RSNA, SAR, SRU and ACR. In addition, he serves as a reviewer for several journals. Dr. Bathala is an active speaker, both nationally and internationally.
Present Title & Affiliation
Primary Appointment
Professor, Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
Professor, Department of Diagnostic Radiology, McGovern Medical School at UT Health, Houston, Texas
Research Interests
Health Services Research
Comparative Effectiveness
Technology Assessment
Cancer Prevention
Quality Improvement
Clinical Interests
Oncological applications of diagnostic ultrasound, CT and MRI
Imaging of genitourinary and gynecological malignancies.
Education & Training
Degree-Granting Education
| 2007 | Bangalore Medical College, affiliated with Rajiv Gandhi University of Health Sciences, Bangalore, IN, MD |
| 2001 | Mysore Medical College, affiliated with Rajiv Gandhi University of Health Sciences, Mysore, IN, Medicine and Surgery, MBBS |
Postgraduate Training
| 2022-2022 | Academy Council for Early Career Investigators in Imaging (CECI2) class of 2022, Academy for Radiology and Biomedical Imaging Research, Washington, DC |
| 2021-2022 | Master of Science in Health Care Transformation, UT Austin McComb School of Business and Dell Medical School, Austin, Texas |
| 2020-2021 | Certificate in Applied Biostatistics, Harvard Medical School, Boston, Massachusetts |
| 2017-2017 | Measurement, Design, and Analysis Methods for Health Outcomes Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts |
| 2017-2018 | Value of imaging through comparative effectiveness research, NYU Langone Medical Center, New York, New York |
| 2017-2017 | Management & Supervision Course, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2014-2014 | Clinical safety and effectiveness program - Quality improvement & patient safety program, Quality and Safety, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2013-2018 | Core curriculum in clinical research and evidence-based medicine, UT McGovern school of medicine and school of public health, Houston, Texas |
| 2013-2014 | Nuclear medicine and positron emission tomography training, The University of Texas MD Anderson Cancer Center, Houston |
| 2012-2013 | Heart of Leadership - Junior faculty leadership course, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2011-2011 | Clinical trial methodology workshop, Radiological Society of North America, Chicago, Texas |
| 2010-2012 | Clinical Fellowship, Body Imaging, Boston University Medical Center, Boston, Massachusetts |
| 2009-2010 | Clinical Fellowship, Vascular and Interventional Radiology, Boston University Medical Center, Boston, Massachusetts |
| 2004-2007 | Clinical Residency, Bangalore Medical College, Bangalore |
| 2002-2004 | Clinical Internship, Bowring & Lady Curzon Hospitals, Bangalore |
| 2001-2002 | Clinical Internship, Mysore Medical College, Mysore |
Licenses & Certifications
| 2016 | American Board of Radiology |
| 2007 | Medical Council of India |
Experience & Service
Faculty Academic Appointments
Associate Professor, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - 2024
Associate Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2018 - 2019
Associate Professor, Department of Diagnostic Radiology, The University of Texas Medical School at Houston, Houston, Texas, 2018 - 2024
Assistant Professor, Department of Diagnostic Radiology, The University of Texas Medical School at Houston, Houston, Texas, 2013 - 2018
Assistant Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2012 - 2018
Administrative Appointments/Responsibilities
Co-Director, General Ultrasound, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2015
Chief Resident, Department of Radiology, Victoria Hospital, Bowring & Lady Curzon Hospital, and other teaching hospitals attached to Bangalore Medical College, Bangalore, 2006 - 2007
Other Professional Positions
Attending Radiologist, Institute of Nephro-Urology, Bangalore, India, 2007 - 2007
Institutional Committee Activities
Chair, Mid-Career Faculty Committee, 2023 - Present
Academic Leadership Team, Chief Academic Officer, 2020 - Present
Member, Mid-Career Faculty Committee, 2020 - Present
Chief Academic Officer, Academic Leadership Team, 2020 - Present
Member, DI Mid-career Faculty Steering Committee, 2018 - 2019
Member, Diagnostic Imaging Clinical Effectiveness & Evidence-Based Imaging Committee, 2017 - Present
Member, Junior Faculty Steering Committee, 2017 - 2018
Member, Clinical Effectiveness Subcommittee, 2016 - Present
Member, General Ultrasound Operation Committee, 2015 - 2018
Member, Diagnostic Imaging Strategic Plan Functional Committee, 2014 - 2019
Member, Diagnostic Imaging Quality Functional Committee, 2014 - Present
Member, Liver Cancer Screening Algorithm and Metrics Committee, 2013 - 2018
Member, Abdominal Imaging Policy Committee, 2013 - 2013
Member, Abdominal Imaging Quality Improvement Committee, 2012 - Present
Member, Magnetic Resonance Imaging Quality Assurance Committee, 2012 - 2021
Member, Prostate Brachytherapy Research Group, 2012 - Present
Member, Clinical Ultrasound Advisory Committee, 2012 - 2014
Honors & Awards
| 2022 | Fellow, Society of Abdominal Radiology |
| 2021 | Award of Distinction for Translational Research, ECOG-ACRIN Young Investigator Symposium |
| 2015 | Diagnostic Imaging Clinical Research Committee Award, The University of Texas MD Anderson Cancer Center |
| 2014 | Diagnostic Imaging Celebrating Solutions Award, The University of Texas MD Anderson Cancer Center |
| 2014 | Clinician Education Development Program, American Roentgen Ray Society |
| 2013 | Certificate of Merit, Radiological Society of North America |
| 2012 | AUR Junior Faculty Development Program, Association of University Radiologists |
| 2009 | Introduction to Research for International Young Academics Travel Award, Radiological Society of North America |
| 2008 | Certificate of Recognition Award, European Congress of Radiology |
| 2007 | Best Outgoing Postgraduate Student of the Academic Year Award, Bangalore Medical College and Research Institute |
| 2007 | Dr. K. Krishnamurthy Gold Medal Award, Rajiv Gandhi University of Health Science |
| 2007 | Professor S.M. Chandrashekar Shetty Gold Medal Award, Rajiv Gandhi University of Health Science |
| 2006 | Best Scientific Poster Award, Indian Radiological and Imaging Association, Karnataka State Chapter |
| 2006 - 2007 | Best Scientific Paper Award, Indian Radiological and Imaging Association, Karnataka State Chapter |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2018. Magnetic resonance imaging of the prostate - screening, diagnosis and surveillance setting. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2017. Prostate cancer imaging: active surveillance management of prostate cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2017. Single sequence magnetic resonance only, post-implant dosimetry of prostate brachytherapy using compressed sensing. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2016. Ovarian cyst management algorithm. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2015. Diagnostic workup with magnetic resonance imaging for prostate cancer. Conference. American Brachytherapy Society. Houston, TX, US.
- 2015. Picture quality imaging project: optimizing general ultrasound workflow. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2015. Value of delayed phase computed tomography images in routine computed tomography abdomen and pelvis: results and analysis of picture quality index project. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2013. Magnetic resonance imaging prostate – optimizing protocol sequences. Conference. American Brachytherapy Society. Houston, TX, US.
- 2013. Vascular ultrasound case studies: ultrasound in the new millennium. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
Regional Presentations
- 2023. Management of PSMA N+ and MRI negative prostate cancer. Conference. UTMD Christopher G. Wood Advances In Urologic Oncology. Austin, TX, US.
National Presentations
- 2025. Introduction to Leadership Panel: Balancing life and career in academic radiology. Panelist. Association of Academic Radiology Annual Meeting. Los Angeles, California, US.
- 2025. Imaging of High Risk and Advanced Prostate Cancer with Emphasis on MRI, PET/CT and PET/MRI. Conference. Tucson, Arizona, US.
- 2024. Genitourinary Imaging. Invited. Radiological Society of North America Annual Meeting. Chicago, Illinois, US.
- 2024. Prostate. Invited. Radiological Society of North America Annual Meeting. Chicago, Illinois, US.
- 2024. A prospective pilot study investigating 18F rhPSMA-7.3 PET/MRI to detect recurrent disease and guide radiotherapy planning in patients with biochemically recurrent prostate cancer post-prostatectomy. Conference. American Society for Radiation Oncology Annual Meeting. Washington DC, US.
- 2024. Common statistical tests for reserach. Conference. Association of University Radiologists Annual Meeting. Boston, MA, US.
- 2024. Quality indicators for prostate cancer imaging services. Conference. Society of Abdominal Imaging Annual Scientific Meeting. Hollywood, FL, US.
- 2024. Imaging of high risk and advanced prostate cancer with emphasis on MRI, PET/CT and PET/MRI. Conference. Society of Abdominal Imaging Annual Scientific Meeting. Hollywood, FL, US.
- 2023. GU essentials! A case-based audience participation session. Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.
- 2023. Research 2: Interactive primer on statistics. Conference. Association of University Radiologist Annual Meeting. Austin, TX, US.
- 2023. Research boot camp. Conference. Association of University Radiologist Annual Meeting. Austin, TX, US.
- 2023. ARRALD Program 1. Conference. Association of University Radiologist Annual Meeting. Austin, TX, US.
- 2023. Case: PSMA +, MRI neg/suspicious. Invited. UT Christopher G. Wood Advances In Urologic Oncology. Austin, TX, US.
- 2023. Imaging of high-risk locally advanced prostate cancer. Conference. Society of Abdominal Imaging Annual Meeting. Austin, TX, US.
- 2023. Quality indicators for prostate cancer imaging services. Conference. Society of Abdominal Imaging Annual Meeting. Austin, TX, US.
- 2023. Prostate MR hands-on workshop. Conference. Society of Abdominal Imaging Annual Meeting. Austin, TX, US.
- 2022. GU essentials! A case-based audience participation session. Invited. Radiological Society of North America Scientific Annual Meeting. Chicago, IL, US.
- 2022. Advances in prostate imaging with emphasis on the role of molecular imaging. Invited. Society of Abdominal Imaging Annual Meeting - Virtual. Scottsdale, AZ, US.
- 2022. Quality indicators for prostate cancer imaging services. Invited. Society of Abdominal Imaging Annual Meeting. Scottsdale, AZ, US.
- 2022. Prostate magnetic resonance imaging-hands on workshop. Invited. Society of Abdominal Imaging Annual Meeting. Maui, HI, US.
- 2021. Clinical importance of secondary imaging interpretations in a cancer hospital and its impact on patient management. Conference. Radiological Society of North America Scientific Annual Meeting. Chicago, IL, US.
- 2021. Imaging high-risk and very high-risk prostate cancer. Invited. Society of Abdominal Imaging Annual Meeting - Virtual. Maui, HI, US.
- 2021. Prostate magnetic resonance imaging-hands on workshop. Invited. Society of Abdominal Imaging Annual Meeting. Maui, HI, US.
- 2020. Extraprostatic extension of prostate cancer. Conference. Society of Abdominal Imaging - DFP Multidisciplinary Symposium. Virtual, US.
- 2020. Ultrasound acute biliary infection/inflammation with computed tomography/magnetic resonance imaging correlation. Invited. Society of Abdominal Imaging Annual Meeting. Maui, HI, US.
- 2020. Imaging high-risk and very high-risk prostate cancer. Invited. Society of Abdominal Imaging Annual Meeting. Maui, HI, US.
- 2020. Prostate magnetic resonance imaging-hands on workshop. Invited. Society of Abdominal Imaging Annual Meeting. Maui, HI, US.
- 2019. Ultrasound imaging of the acute biliary infections, inflammations, and infiltrations with CT/MR. Invited. Society of Abdominal Radiology Annual Meeting. Orlando, FL, US.
- 2019. Sonography of the abdominal wall as a problem solving tool: pearls and pitfalls. Invited. Society of Abdominal Radiology Annual Meeting. Orlando, FL, US.
- 2019. Prostate magnetic resonance imaging-hands on workshop. Invited. Society of Abdominal Imaging Annual Meeting. Maui, HI, US.
- 2018. Comprehensive radiogenomic analysis of qualitative and quantitative features of crossectional imaging in the TCGA project in MIBC. Conference. Society of Urological Oncology Annual Meeting, US.
- 2018. Primary tumor response to neo-adjuvant androgen therapy assessed by pre-post treatment MRI prior to radical prostatectomy. Conference. American Urological Association Annual Meeting. San Francisco, CA, US.
- 2018. Multiparametric magnetic resonance imaging for detection of prostate cancer lesions and extraprostatic extension in high risk prostate cancer patients undergoing prostatectomy. Conference. American Urological Association Annual Meeting. San Francisco, CA, US.
- 2018. Prostate MR sequence optimization for radiotherapy planning: quality of 3D T2W space vs 2D T2W TSE in the evaluation of prostate and periprostatic anatomy. Conference. Society of Abdominal Radiology Annual Meeting. Scottsdale, AZ, US.
- 2018. Is expanded radiographic criteria for clinically positive lymph nodes associated with outcome in pathologically node positive prostate cancer?. Conference. Genitourinary Cancers Symposium. San Francisco, CA, US.
- 2017. Computed tomography scan has high rate of incidental findings and low clinical utility in a cohort of high risk prostate cancer patients staged with 99MTC bone scan and pelvic MR. Conference. Society of Urologic Oncology Annual Meeting. Washington D.C, MD, US.
- 2017. True FISP for single sequence mr-only post-implant dosimetry of prostate brachytherapy. Conference. American Association of Physicists in Medicine Annual Meeting. Nashville, TN, US.
- 2017. Does delayed phase post-contrast computed tomography imaging of the kidneys and bladder add value in the computed tomography imaging assessment of patients with a hematological malignancy?. Conference. American College of Radiology Annual Meeting. Washington D.C, MD, US.
- 2017. Acalculous cholecystitis in patients with acute hematological malignancies: Prognostic significance of sonographic gallbladder findings. Conference. Society of Abdominal Radiology Annual Scientific Meeting. Hollywood, FL, US.
- 2016. Sonography of the abdominal wall as a problem solving tool: Pearls and pitfalls. Invited. Society of Abdominal Radiology Annual Scientific Meeting. Waikoloa, HI, US.
- 2015. Defining the cost of advanced imaging technology in image-guided radiation therapy using time-driven activity-based costing. Conference. Radiological Society of North America Scientific Annual Meeting Program. Chicago, IL, US.
- 2015. Designing and implementing an innovative phantom-based simulator training program for prostate brachytherapy using advanced magnetic resonance imaging. Conference. Radiological Society of North America Scientific Annual Meeting. Chicago, IL, US.
- 2015. Defining the cost of advanced imaging technology in image-guided radiation therapy using time-driven activity-based costing. Invited. Radiological Society of North America Scientific Annual Meeting. Chicago, IL, US.
- 2015. Optimization of pelvic magnetic resonance imaging for prostate brachytherapy. Invited. Radiological Society of North America Annual Scientific Meeting. Chicago, IL, US.
- 2015. BOOST: genitourinary-integrated science and practice session designing and implementing an innovative phantom-based simulator training program for prostate brachytherapy using advanced magnetic resonance imaging. Invited. Radiological Society of North America Scientific Annual Meeting. Chicago, IL, US.
- 2015. Slow blood flow in lower extremity deep veins on doppler ultrasound examination: Does it predict subsequent development of deep vein thrombosis?. Invited. Radiological Society of North America Annual Scientific Meeting. Chicago, IL, US.
- 2015. Familial tumors of the female genital system; multi-modality imaging with pathologic correlation. Conference. Radiological Society of North America Scientific Annual Meeting. Chicago, IL, US.
- 2015. Sonography of the abdominal wall as a problem-solving tool: pearls and pitfalls. Invited. Society of Abdominal Radiology Annual Scientific Meeting. San Diego, CA, US.
- 2015. Cancer immunotherapy and anti-angiogenic therapy: detecting complications and avoiding pitfalls. Invited. Society of Abdominal Radiology Annual Scientific Meeting. San Diego, CA, US.
- 2014. Desmoplastic small round cell tumor: a comprehensive, single-institution study of 94 cases. Conference. Radiology Society of North America Annual Scientific Meeting. Chicago, TX, US.
- 2013. Diagnostic performance of conventional ultrasonography combined with ultrasound strain elastography for differentiation between benign and malignant subcutaneous soft tissue mass lesions. Conference. Radiological Society of North America Annual Scientific Meeting. Chicago, IL, US.
- 2013. Oncogenetics of clear renal cell carcinoma in the era of personalized medicine: What radiologist needs to know. Conference. Radiological Society of North America Annual Scientific Meeting. Chicago, IL, US.
- 2013. The role of intra-operative ultrasound in oncologic therapy. Conference. Radiology Society of North America Annual Scientific Meeting. Chicago, IL, US.
- 2011. Use of minimum intensity pixel projection reformations in computed tomography enterography of Crohn's disease - a pictorial review. Conference. Annual Meeting of the Society of Gastrointestinal Radiology. Carlsbad, CA, US.
- 2011. Imaging in ileal pouch-anal anastomosis surgery: A pictorial review. Conference. Annual Meeting of the Society of Gastrointestinal Radiology. Carlsbad, CA, US.
- 2010. Chronic lower extremity venous disease: classification, diagnosis and endovascular treatment. Conference. Radiological Society of North America Annual Scientific Meeting. Chicago, IL, US.
- 2010. Percutaneous embolization of nasopharyngeal angiofibroma: technical strategies. Conference. Annual Meeting of the American Society of Neuroradiology. Boston, MA, US.
- 2010. Interesting cases of the month. Invited. Monthly Scientific Meeting of New England Society of Interventional Radiology. Boston, MA, US.
- 2010. TIPS reduction: when and how. Conference. Society of Interventional Radiology Annual Scientific Meeting. Tampa, FL, US.
- 2009. Interesting cases of the month. Invited. Monthly Scientific Meeting of New England Society of Interventional Radiology. Boston, MA, US.
International Presentations
- 2023. Spatial modulation of magnetization tagged EPI acquisition for visualization of geometric distortion caused by an endorectal coil. Conference. International Society of Magnetic Resonance Imaging, CA.
- 2023. PO-1473 PSMA PET imaging of non-acinar histological variants of prostate cancer. Conference. European Society for Radiotherapy and Oncology, AT.
- 2022. Panel discussion on Imaging and management of high-risk prostate cancer. Conference. at American Urology Association Annual Meeting, International Prostate Forum. New Orleans, US.
- 2021. Quality of prostate MRI. Conference. American Urology Association Annual Meeting, International Prostate Forum, US.
- 2015. Magnetic resonance imaging in cervical cancer. Invited. Annual conference of Indian Radiological and Imaging Association. Cochin, IN.
- 2015. Role of magnetic resonance imaging of rectal cancer. Invited. Annual conference of Indian Radiological and Imaging Association. Cochin, IN.
- 2014. Magnetic resonance imaging in rectal cancer. Invited. Oncoradiology and interventional Radiology CME. Bangalore, IN.
- 2014. Imaging strategies for the evaluation of uterine cervical cancer. Invited. Oncoradiology and interventional Radiology CME. Bangalore, IN.
- 2014. Imaging in oncological emergencies. Invited. Oncoradiology and interventional Radiology CME. Bangalore, IN.
- 2014. Imaging & staging of prostate cancer: when and how. Invited. Oncoradiology and Interventional Radiology CME. Bangalore, IN.
- 2012. Liver MRI – OPTN and LI-RAD classification. Invited. National Conference of Indian Radiological and Imaging Association. Hyderabad, IN.
- 2010. Recannalization of occluded popliteal stent with mechanical thrombectomy and distal embolic protection device. Conference. Annual Scientific Meeting Cardiovasular and Interventional Radiological Society of Europe. Valencia, ES.
- 2010. Pudendal arteriography in trauma patients. Conference. Annual Scientific Meeting Cardiovascular and Interventional Radiological Society of Europe. Valencia, ES.
- 2009. Digital mammography: experience in Bahamas. Invited. Annual Scientific Conference of Medical Association of Bahamas. Nassau, BS.
- 2008. The Bahamas interventional cardiology center acute coronary syndrome-coronary calcium score study. Invited. Caribbean Cardiac Society Caribbean Cardiology Conference. Nassau, BS.
- 2008. Junior image interpretation quiz: Europe vs. India. Invited. European Congress of Radiology. Vienna, AT.
- 2008. Computed tomography urography: technique and application. Invited. National Conference of Indian Radiological and Imaging Association. Bangalore, IN.
- 2007. Pictorial essay of traumatic kidney lesions by multidetector computed tomography. Conference. Annual Karnataka State Level Conference of Indian Radiological and Imaging Association. Bangalore, IN.
- 2006. Image guided percutaneous drainage of liver abscess – our experience in 2 years. Invited. Annual Karnataka State Level Conference of Indian Radiological and Imaging Association. Bangalore, IN.
- 2006. Transvaginal ultrasonographic assessment of cervix as predictor of preterm delivery in at risk women. Invited. Annual Congress of Indian Radiological and Imaging Association. Chennai, IN.
- 2005. Pictorial essay of breast lesions by imaging modalities. Conference. Annual Karnataka State Level Conference of Indian Radiological and Imaging Association. Mangalore, IN.
Formal Peers
- 2022. MRI Imaging of High-Risk Prostate Cancer, Grand Round. Visiting. Stony Brook, NY, US.
- 2015. Imaging in oncological emergencies. Visiting. Houston, TX, US.
- 2013. Abdominal imaging lecture and resident board reviews for ABR. Visiting. Syracuse, NY, US.
- 2013. Abdominal imaging lecture and resident board reviews for ABR. Visiting. Birmingham, AL, US.
Grant & Contract Support
| Date: | 2024 - Present |
| Title: | Neoadjuvant theranostic lutetium study: The Nautilas trial |
| Funding Source: | Nautilas |
| Role: | Collaborator |
| ID: | 2022-0500 |
| Date: | 2021 - 2024 |
| Title: | 5%, Diagnostic performance of non-endorectal coil multiparametric magnetic resonance imaging of prostate with flexible AIR coil - DoNEMAC study |
| Funding Source: | Internal Funding |
| Role: | PI |
| Date: | 2021 - 2024 |
| Title: | 1%, Development & evaluation of a quantitative HP MRI clinical prostate cancer exam |
| Funding Source: | Internal Funding |
| Role: | PI |
| Date: | 2020 - 2024 |
| Title: | 1%, Response evaluation of finite systemic therapy with advanced androgen signaling inhibition and radiation therapy for oligorecurrent prostate cancer (RESTART), FP00008691 |
| Funding Source: | Department of Defense |
| Role: | Co-I |
| Date: | 2020 - 2022 |
| Title: | 5%, nonEndo 3D T2W MR imaging study for prostate cancer |
| Funding Source: | UT Austin/MD Anderson Cancer Center Collaborative Pilot Project Grants |
| Role: | PI |
| Date: | 2019 - 2024 |
| Title: | Multiparametric MRI for preoperative staging and treatment planning for newly-diagnosed prostate cancer |
| Funding Source: | ECOG-ACRIN |
| Role: | National PI |
| ID: | ECOG-ACRINEA8171 |
| Date: | 2018 - 2023 |
| Title: | EXTernal beam radiation to eliminate nominal metastatic disease - EXTEND: A randomized phase II basket trial to assess local control for oligometastatic disease |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | RP180140 |
| Date: | 2015 - 2016 |
| Title: | The University of Texas Kenneth I. Shine Academy of Health Science Education Small Grants Program |
| Funding Source: | UT Health Science Education Small Grant Program |
| Role: | PI |
| Date: | 2015 - 2017 |
| Title: | 10%, Magnetic resonance imaging as a comprehensive staging tool for the evaluation of high - risk prostate carcinoma |
| Funding Source: | Internal Division Grant |
| Role: | Principal Investigator-MDACC |
| Date: | 2015 - 2017 |
| Title: | Developing an educational curriculum for teaching the cancer staging, PA15-0125 |
| Funding Source: | University of Texas educational grant |
| Role: | PI |
| Date: | 2014 - 2021 |
| Title: | 1%, Mobile-health delivery of a comprehensive lifestyle intervention for lymphoma patients |
| Funding Source: | Gabrielle's Angel Foundation for Cancer Research |
| Role: | Co-PI |
| ID: | FP00011812 |
| Date: | 2014 - 2015 |
| Title: | A framework for the analysis of multiparametric MRI data and the application for disease control with tumor response assessment |
| Funding Source: | The Center for Radiation Oncology Research |
| Role: | Collaborator |
| Date: | 2013 - 2014 |
| Title: | MRI based simulation and treatment planning for localized prostate cancer |
| Funding Source: | ELEKTA |
| Role: | Collaborator |
| Date: | 2010 |
| Title: | Boston University Radiology Research fund |
| Funding Source: | Boston University Radiology Program |
| Role: | Trainee |
| Date: | 2008 |
| Title: | Travel grant to attend RSNA Introduction to Academic Radiology program |
| Funding Source: | Radiological Society of North America |
| Role: | Radiologist |
| Date: | 2008 |
| Title: | Travel grant to attend European Congress of Radiology as junior image interpretation session panelist |
| Funding Source: | Indian Radiological and Imaging Association |
| Role: | Trainee |
| ID: | Travel Grant |
Selected Publications
Peer-Reviewed Articles
- Bathala TK, Mohamad O, Bruno T, Wang L, Kudchakar R, Bathala TK, Sanders J, Mok H, McGuire S, Kuban D, Hoffman K, Nguyen Q, Park R, Thames H, Corn P, Chapin B, Choi S, Tang C, Frank S. Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences. Brachytherapy 24(2):231-237, 2025. e-Pub 2025. PMID: 39755443.
- Reddy J, Sherry A, Fellman B, Liu S, Bathala TK, Haymaker C, Cohen L, Smith B, Ramirez D, Shaitelman S, Chun S, Medina-Rosales M, Teshome M, Brewster A, Barcenas C, Reuben A, Ghia A, Ludmir E, Weed D, Shah S, Mitchell M, Woodward W, Gomez D, Tang C. Adding metastasis-directed therapy to standard-of-care systemic Therapy for oligometastatic breast cancer: A multicenter, randomized phase 2 trial. Int J Radiat Oncol Biol Phys 121(4):885-893, 2025. e-Pub 2025. PMID: 39486645.
- Moussa, MJ, Khandelwal, J, Wilson, NR, Malikayil, KL, Surasi, DS, Bathala, TK, Lin, Y, Rao, P, Tamboli, P, Sircar, K, Ajufo, HO, Elsayes, KM, Shah, AY, Johns, AC, Goswami, S, Hasanov, E, Jonasch, E, Msaouel, P, Campbell, M, Alhalabi, O, Tannir, NM. Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma. Journal for immunotherapy of cancer 13(2), 2025. e-Pub 2025. PMID: 39939142.
- Ludmir EB, Sherry AD, Fellman BM, Liu S, Bathala T, Haymaker C, Medina-Rosales MN, Reuben A, Holliday EB, Smith GL, Noticewala SS, Nicholas S, Price TR, Martin-Paulpeter RM, Perles LA, Lee SS, Lee MS, Smaglo BG, Huey RW, Willis J, Zhao D, Cohen L, Taniguchi CM, Koay EJ, Katz MHG, Wolff RA, Das P, Pant S, Koong AC, Tang C. Addition of metastasis-directed therapy to systemic therapy for oligometastatic pancreatic ductal adenocarcinoma: A multicenter, randomized phase II trial. J Clin Oncol 10(42):3795-3805, 2024. e-Pub 2024. PMID: 39102622.
- Fang Andrew, Chapin Brian, Shi Charles, Sun Jia, Kundra Vikas, Corn Paul, Kuban Deborah, Ravizzini Gregory, Surasi Devaki, MA Jingfei, Bathala TK. Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancer. Prostate Cancer Prostatic Dis, 2024. e-Pub 2024. PMID: 39289537.
- Hahn AW, Surasi DS, Viscuse PV, Bathala TK, Wiele AJ, Campbell MT, Zurita AJ, Shah AY, Jonasch E, Gao J, Goswami S, Alhalabi O, Rao P, Sircar K, Tannir NM, Msaouel P. Treatment outcomes in patients with metastatic renal cell carcinoma with sarcomatoid and/or rhabdoid dedifferentiation after progression on immune checkpoint therapy. Oncologist 29(5):392-399, 2024. e-Pub 2024. PMID: 38035767.
- Wang L, Ding Y, Bruno TL, Stafford RJ, Lin E, Bathala TK, Sanders JW, Ning MS, Ma J, Klopp AH, Venkatesan A, Wang J, Martirosyan KS, Frank SJ. A novel positive-contrast magnetic resonance imaging line marker for high-dose-rate. MRI-assisted radiosurgery. Cancers 16(10), 2024. e-Pub 2024. PMID: 38792000.
- Fang AM, Jackson J, Gregg JR, Chery L, Tang C, Surasi DS, Siddiqui BA, Rais-Bahrami S, Bathala T, Chapin BF. Correction to: Surgical management and considerations for patients with localized high-risk prostate cancer. Curr Treat Options Oncol 25(5):617-618, 2024. e-Pub 2024. PMID: 38642282.
- Hinchcliff EM, Knisely A, Adjei N, Fellman B, Yuan Y, Patel A, Xu C, Westin SN, Sood AK, Soliman PT, Shafer A, Fleming ND, Gershenson DM, Vikram R, Bathala TK, Vining D, Ganeshan DM, Lu KH, Sun CC, Meyer LA, Jazaeri AA. Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer 130(7):1061-1071, 2024. e-Pub 2024. PMID: 38009662.
- Awiwi MO, Gjoni M, Vikram R, Altinmakas E, Dogan H, Bathala TK, Naik S, Ravizzini G, Kandemirli SG, Elsayes KM, Salem UI. MRI and PSMA PET/CT of biochemical recurrence of prostate cancer. Radiographics 43(12):e230112, 2023. e-Pub 2023. PMID: 37999983.
- Giganti, F, Ng, A, Asif, A, Wai-Shun Chan, V, Rossiter, M, Nathan, A, Khetrapal, P, Dickinson, L, Punwani, S, Brew-Graves, C, Freeman, A, Emberton, M, Moore, CM, Allen, C, Kasivisvanathan, V, Dias, AB, Haider, A, Khan, A, Tong, A, Rannikko, A, Kenttämies, A, Rastinehad, A, Stabile, A, Villers, A, Tewari, A, Oto, A, Israël, B, Gaing, B, Cho, CM, González, CA, Lee, CH, Wetterauer, C, Kesch, C, Adamo, DA, Margolis, D, López Ruiz, DJ, Margel, D, Murphy, DG, Gomez, EG, Chun, FK, Preisser, F, Thomas, F, Villeirs, GM, Marra, G, Giannarini, G, Brembilla, G, Robert, G, Manenti, G, Ma, J, Bathala, TK. Global Variation in Magnetic Resonance Imaging Quality of the Prostate. Radiology 309(1), 2023. e-Pub 2023. PMID: 37815448.
- Andring LM, Abu-Gheida I, Bathala TK, Yoder AK, Manzar GS, Maldonado JA, Frank SJ, Choi S, Nguyen QN, Hoffman K, McGuire SE, Mok H, Aparicio A, Chapin BF, Tang C. Definitive local therapy for T4 prostate cancer associated with improved local control and survival. BJU Int 132(3):307-313, 2023. e-Pub 2023. PMID: 37057728.
- Tang C, Sherry AD, Haymaker C, Bathala TK, Liu S, Fellman B, Cohen L, Aparicio A, Zurita AJ, Reuben A, Marmonti E, Chun SG, Reddy JP, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Pilie P, Kovitz C, Du W, Simiele SJ, Kumar R, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn PG. Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer: The EXTEND phase 2 randomized clinical trial. JAMA Oncol 9(6):825-834, 2023. e-Pub 2023. PMID: 37022702.
- Sherry AD, Bathala T, Liu S, Fellman BM, Chun SG, Jasani N, Guadagnolo BA, Jhingran A, Reddy JP, Corn PG, Shah AY, Kaiser KW, Ghia AJ, Gomez DR, Tang C. Definitive local consolidative therapy for oligometastatic solid tumors: Results from the lead-in phase of the randomized basket trial EXTEND. Int J Radiat Oncol Biol Phys 114(5):910-918, 2022. e-Pub 2022. PMID: 35691448.
- Virarkar, M, Jensen, CT, Klekers, AR, Wagner-Bartak, N, Devine, CE, Lano, EA, Sun, J, Bathala, TK, Bhosale, PR. Clinical importance of second-opinion interpretations of abdominal imaging studies in a cancer hospital and its impact on patient management. Clinical Imaging 86:13-19, 2022. e-Pub 2022. PMID: 35313164.
- Virarkar M, Jensen C, Klekers A, Wagner-Bartak N, Devine C, Lano E, Sun J, Bathala TK, Bhosale, P. Clinical importance of second-opinion interpretations of abdominal imaging studies in a cancer hospital and its impact on patient management. Clinical Imaging 86:13-19, 2022. e-Pub 2022.
- Ranasinghe WKB, Troncoso P, Surasi DS, Ibarra Rovira JJ, Bhosale P, Szklaruk J, Kokorovic A, Wang X, Elsheshtawi M, Zhang M, Aparicio A, Chapin BF, Bathala TK. Defining diagnostic criteria for prostatic ductal adenocarcinoma at multiparametric MRI. Radiology 303(1):110-118, 2022. e-Pub 2022. PMID: 35076303.
- Thaker NG, Kudchadker RJ, Incalcaterra JR, Bathala TK, Kaplan RS, Agarwal A, Kuban DA, Frank BD, Das P, Feeley TW, Frank SJ. Improving efficiency and reducing costs of MRI-guided prostate brachytherapy using time-driven activity-based costing. Brachytherapy 21(1):49-54, 2022. e-Pub 2022. PMID: 34389265.
- Taher A, Jensen C, Yedururi S, Surasi D, Faria S, Bathala TK, Mujtaba B, Bhosale P, Wagner-Bartak N, Morani A. Imaging of neuroendocrine prostatic carcinoma. Cancers 13(22):5765, 2021. e-Pub 2021. PMID: 34830919.
- Kamal O, Foster BR, Turner K, Verma S, Woo S, Bathala TK, Coakley FV. Cowper's gland hyperplasia: A potential pitfall at MRI of the prostate. Clin Imaging 79:337-340, 2021. e-Pub 2021. PMID: 34399290.
- Urkmez A, Demirel C, Altok M, Bathala TK, Shapiro DD, Davis JW. Freehand versus grid-based transperineal prostate biopsy: A comparison of anatomical region yield and complications. J Urol 206(4):894-902, 2021. e-Pub 2021. PMID: 34100650.
- Surasi DSS, Wang X, Bathala TK, Hwang H, Arora S, Westphalen AC, Chang SD, Turkbey B. The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal radiology prostate cancer disease-focused panel survey analysis. Abdom Radiol 46(9):4362-4369, 2021. e-Pub 2021. PMID: 33904992.
- Siddiqui BA, Gheeya JS, Goswamy R, Bathala TK, Surasi DS, Gao J, Shah A, Campbell MT, Msaouel P, Goswami S, Wang J, Zurita AJ, Jonasch E, Corn PG, Aparicio AM, Siefker-Radtke AO, Sharma P, Subudhi SK, Tannir N. Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events. J Immunother Cancer 9(7), 2021. e-Pub 2021. PMID: 34326169.
- Wiele AJ, Bathala TK, Hahn AW, Xiao L, Duran M, Ross JA, Jonasch E, Shah AY, Campbell MT, Msaouel P, Tannir NM. Lenvatinib with or without everolimus in patients with metastatic renal cell carcinoma after immune checkpoint inhibitors and vascular endothelial Growth factor receptor-tyrosine kinase inhibitor therapies. Oncologist 26(6):476-482, 2021. e-Pub 2021. PMID: 33792094.
- Wiele AJ, Surasi DS, Rao P, Sircar K, Su X, Bathala TK, Shah AY, Jonasch E, Cataldo VD, Genovese G, Karam JA, Wood CG, Tannir NM, Msaouel P. Efficacy and safety of bevacizumab plus erlotinib in patients with renal medullary carcinoma. Cancers 13(9), 2021. e-Pub 2021. PMID: 33946504.
- Ranasinghe W, Shapiro DD, Hwang H, Wang X, Reichard CA, Elsheshtawi M, Achim MF, Bathala TK Tang C, Aparicio A, Tu SM, Navone N, Thompson TC, Pisters L, Troncoso P, Davis JW, Chapin BF. Ductal prostate cancers demonstrate poor outcomes with conventional therapies. Eur Urol 79(2):298-306, 2021. e-Pub 2021. PMID: 33279304.
- Sanders JW, Venkatesan AM, Levitt CA, Bathala TK, Kudchadker RJ, Tang C, Bruno TL, Starks C, Santiago E, Wells M, Weaver CP, Ma J, Frank SJ. Fully balanced SSFP without an endorectal coil for postimplant QA of MRI-assisted radiosurgery of prostate cancer: A prospective study. Int J Radiat Oncol Biol Phys 109(2):614-625, 2021. e-Pub 2021. PMID: 32980498.
- Thaker NG, Kudchadker R, Incalcaterra J, Bathala TK, Kaplan RS, Agarwal A, Kuban DA, Frank BD, Das P, Feeley TW, Frank SJ. Improving efficiency and reducing costs of MRI-assisted radiosurgery for prostate brachytherapy by using time-driven activity-based costing. Brachytherapy 21(1):49-54, 2021. e-Pub 2021. PMID: 34389265.
- Chahoud J, Msaouel P, Ross JA, McCormick BZ, Bathala TK, Gao J, Horn R, Xiao L, Sircar K, Campbell MT, Shah AY, Goswami S, Zurita AJ, Jonasch E, Matin SF, Wood CG, Karam JA, Sharma P, Tannir NM. Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors. Urol Oncol 39(2):134.e9-134.e16, 2021. e-Pub 2021. PMID: 33187886.
- Surasi DSS, Lu Y, Corn P, Pettaway C, Bathala TK. Incidental detection of urothelial carcinoma on 18F-fluciclovine PET/CT. Clin Nucl Med 46(2):e114-e115, 2021. e-Pub 2021. PMID: 33156041.
- Greg Justin R, Shilpa SD, Alexandra C, Nicholas M, Ward John F, Jeri K, Daniel Carrie R, Christopher L, Bathala TK, Davis John W. The association of peri-prostatic fat and grade group progression in men with localized prostate cancer on active surveillance. Journal of Urology 205(1):122-128, 2021. e-Pub 2021. PMID: 32718204.
- Reichard CA, Kukreja J, Gregg JR, Bathala TK, Achim MF, Wang X, Davis JW, Nguyen QN, Chapin BF. Prediction of organ-confined disease in high and very high-risk prostate cancer patients staged with magnetic resonance imaging: implications for clinical trial design. Eur Urol Focus 7(1):71-77, 2021. e-Pub 2021. PMID: 31076357.
- Kim M, Abu-Ghedia I, Bathala TK, Maldonado J, Khan M, Anscher M, Frank S, Choi S, Nguyen Q, Hoffman K, McGuire S, Kuban D, Aparicio A, Chapin B, Tang C. Comparisons of treatment outcomes and patterns of lymph node involvement in T4 prostate cancer patients. International Journal of Radiation Oncology*Biology*Physics 108(Issue 3, Supplement 1):e912, 2020. e-Pub 2020.
- Boyce-Fappiano D, Bathala TK, Ye R, Pasalic D, Gjyshi O, Pezzi TA, Noticewala SS, McGinnis GJ, Maroongroge S, Kuban DA, Nguyen QN, McGuire SE, Hoffman KE, Choi S, Tang C, Kudchadker RJ, Frank SJ. Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy. Brachytherapy 19(5):574-583, 2020. e-Pub 2020. PMID: 32682778.
- Chetlen A, Petscavage-Thomas J, Cherian R, Ulano A, Nandwana S, Curci N, Swanson R, Artrip R, Bathala TK, Gettle L, Frigini L. Collaborative learning in radiology: from peer review to peer learning and peer coaching. Academic Radiology 27(9):1261-1267, 2020. e-Pub 2020. PMID: 31636005.
- Abu-Gheida I, Bathala TK, Maldonado JA, Khan M, Anscher MS, Frank SJ, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Kim M, Kuban DA, Aparicio A, Chapin BF, Tang C. Increased frequency of mesorectal and perirectal LN involvement in T4 prostate cancers. Int J Radiat Oncol Biol Phys 1(107):982-985, 2020. e-Pub 2020. PMID: 32353391.
- Morani A, Hanafy A, Marcal L, Subbiah V, Le O, Bathala TK, Elsayes K. Imaging of acute abdomen in cancer patients. Abdominal Radiology 45(8):2287-2304, 2020. e-Pub 2020. PMID: 31758230.
- Bathala TK, Venkatesan AM, Ma J, Bhosale P, Wei W, Kudchadker RJ, Wang J, Anscher MS, Tang C, Bruno TL, Frank SJ, Szklaruk J. Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy. Brachytherapy 19(4):484-490, 2020. e-Pub 2020. PMID: 32402544.
- Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, Bathala TK, Bittencourt LK, Booker MT, Braxton VG, Carroll PR, Casalino DD, Chang SD, Coakley FV, Dhatt R, Eberhardt SC, Foster BR, Froemming AT, Fütterer JJ, Ganeshan DM, Gertner MR, Mankowski Gettle L, Ghai S, Gupta RT, Hahn ME, Houshyar R, Kim C, Kim CK, Lall C, Margolis DJA, McRae SE, Oto A, Parsons RB, Patel NU, Pinto PA, Polascik TJ, Spilseth B, Starcevich JB, Tammisetti VS, Taneja SS, Turkbey B, Verma S, Ward JF, Warlick CA, Weinberger AR, Yu J, Zagoria RJ, Rosenkrantz AB. Variability of the positive predictive value of PI-RADS for prostate magnetic resonance imaging across 26 centers: experience of the Society of Abdominal Radiology prostate cancer disease-focused panel. Radiology 296(1):76-84, 2020. e-Pub 2020. PMID: 32315265.
- Ranasinghe Weranja B, Brooks Nathan A, Elsheshtawi Mohamed A, David John W, Bathala TK, Chad T, Patricia T, Ana A, Shi-Ming T, Pisters Louis L, Chapin Brian F. Patterns of metastases of prostatic ductal adenocarcinoma. Cancer 126(16):3367-3673, 2020. e-Pub 2020. PMID: 32453443.
- Chen B, Bathala TK, Xu G, Teyateeti A, Chapin BF, Tang C, Tu SM, Macapinlac HA, Lu Y. Comparison of diagnostic utility of fluciclovine positron emission tomography/computed tomography versus pelvic multiparametric magnetic resonance imaging for prostate cancer in the pelvis in the setting of rising prostate specific antigen after initial treatment. Clin Nucl Med 45(5):349-355, 2020. e-Pub 2020. PMID: 31977495.
- Ranasinghe W, Reichard C, Bathala T, Chapin B. Management of cT4 prostate cancer. European Urology Focus 6(2):221-226, 2020. e-Pub 2020. PMID: 31266732.
- Baack Kukreja J, Bathala TK, Reichard CA, Troncoso P, Delacroix S, Davies B, Eggener S, Smaldone M, Minhaj Siddiqui M, Tollefson M, Chapin BF. Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer. Prostate Cancer Prostatic Dis 23(1):172-178, 2020. e-Pub 2020. PMID: 31501508.
- Chahoud J, Msaouel P, Campbell MT, Bathala T, Xiao L, Gao J, Zurita AJ, Shah AY, Jonasch E, Sharma P, Tannir NM. Nivolumab for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A single-institutional experience and literature meta-analysis. Oncologist 25(3):252-258, 2020. e-Pub 2020. PMID: 32162795.
- Virarkar M, Iyer R, Bhosale P, Bathala TK, Chong W, Shroff G. Esophageal pneumatosis: case report and review of literature. Clinical Imaging 58:15-21, 2019. e-Pub 2019.
- Morani AC, Bathala TK, Surabhi VR, Yedururi S, Jensen CT, Huh WW, Prasad S, Hayes-Jordan A. Desmoplastic small round cell tumor: imaging pattern of disease at presentation. AJR Am J Roentgenol 212(3):W45-W54, 2019. e-Pub 2019. PMID: 30673334.
- Jensen CT, Blair KJ, Wagner-Bartak NA, Vu LN, Carter BW, Sun J, Bathala TK, Gupta S. Comparison of abdominal computed tomographic enhancement and organ lesion depiction between weight-based scanner software contrast dosing and a fixed-dose protocol in a tertiary care oncologic center. J Comput Assist Tomogr 43(1):155-162, 2019. e-Pub 2019. PMID: 30211799.
- Thampy R, Khan A, Zaki IH, Wei W, Korivi BR, Staerkel G, Bathala TK. Acute acalculous cholecystitis in hospitalized patients with hematologic malignancies and prognostic importance of gallbladder ultrasound findings. J Ultrasound Med 38(1):51-61, 2019. e-Pub 2019. PMID: 29708270.
- Sanders JW, Song H, Frank SJ, Bathala TK, Venkatesan AM, Anscher M, Tang C, Bruno TL, Wei W, Ma J. Parallel imaging compressed sensing for accelerated imaging and improved signal-to-noise ratio in magnetic resonance imaging-based postimplant dosimetry of prostate brachytherapy. Brachytherapy 17(5):816-824, 2018. e-Pub 2018. PMID: 29880449.
- Martin GV, Pugh TJ, Mahmood U, Kudchadker RJ, Wang J, Bruno TL, Bathala TK, Blanchard P, Frank SJ. Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers. Brachy 16(4):761-769, 2017. e-Pub 2017. PMID: 28501429.
- Ma J, Moerland MA, Venkatesan AM, Bathala TK, Kudchadker RJ, Brock KK, Frank SJ. Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy. Brachy 16(4):743-753, 2017. e-Pub 2017. PMID: 28063817.
- Martin GV, Pugh TJ, Mahmood U, Kudchadker RJ, Wang J, Bruno TL, Bathala TK, Frank SJ. Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imaging. Brachy 16(4):728-733, 2017. e-Pub 2017. PMID: 28284511.
- Matrana MR, Bathala TK, Campbell MT, Duran C, Shetty A, Teegavarapu P, Kalra S, Xiao L, Atkinson B, Corn P, Jonasch E, Tannir NM. Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with front-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: A single institution experience. BJU Int 118(2):264-71, 2016. e-Pub 2016. PMID: 26573089.
- Blanchard P, Pugh T, Mahmood U, Swanson D, Graber W, Wang J, Bathala TK, Lim T, Bruno T, Martin G, Kudchadker R, Frank S. MRI simulation for LDR prostate brachytherapy: Can we replace ultrasound with MRI for treatment planning? Comparison of pre-planning, day 0 and day 30 MR dosimetry. Brachytherapy 15(Supplement 1), 2016. e-Pub 2016.
- Lim TY, Kudchadker RJ, Wang J, Bathala TK, Szklaruk J, Pugh TJ, Mahmood U, Ibbott GS, Frank SJ. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: Initial patient experience. J Contemp Brachy 8(3):235-42, 2016. e-Pub 2016. PMID: 27504133.
- Shinagare AB, Vikram R, Jaffe C, Akin O, Kirby J, Huang E, Freymann J, Sainani NI, Sadow CA, Bathala TK, Rubin DL, Oto A, Heller MT, Surabhi VR, Katabathina V, Silverman SG. Radiogenomics of clear cell renal cell carcinoma: preliminary findings of the cancer genome atlas-renal cell carcinoma imaging research group. Abdom Imaging 40(6):1684-92, 2015. e-Pub 2015. PMID: 25753955.
- Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V. Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol 204(5):1031-41, 2015. e-Pub 2015. PMID: 25905938.
- Fang Andrew, Gregg Justin, Pettaway Curtis, Ma Jingfei, Szklaruk Janio, Bathala TK, Surasi Devaki, Chapin Brian. Whole-body MRI for staging prostate cancer: a narrative review. BJU 135(1):13-21, 2015. e-Pub 2015. PMID: 39308142.
- Bhosale PR, Wei W, Ernst RD, Bathala TK, Reading RM, Wood CG, Bedi DG. Intraoperative sonography during open partial nephrectomy for renal cell cancer: does it alter surgical management?. AJR Am J Roentgenol 203(4):822-7, 2014. e-Pub 2014. PMID: 25247947.
- Atkinson BJ, Kalra S, Wang X, Bathala TK, Corn P, Tannir NM, Jonasch E. Clinical outcomes in metastatic renal cell carcinoma patients treated with alternative sunitinib schedules. J Urol 191(3):611-8, 2014. e-Pub 2014. PMID: 24018239.
- Ganeshan D, Morani A, Ladha H, Bathala TK, Kang H, Gupta S, Lalwani N, Kundra V. Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: role of multidetector computed tomography. Abdom Imaging 39(1):66-85, 2014. e-Pub 2014. PMID: 24077815.
- Korivi BR, Jensen CT, Patnana M, Patel KP, Bathala TK. A rare presentation of lymphoma of the cervix with cross-sectional imaging correlation. Case Rep Radiol 2014:1-5, 2014. e-Pub 2014. PMID: 24864220.
- Nwawka OK, Bathala TK, Kabutey NK, Kim D. Simple technique for transjugular intrahepatic portosystemic shunt reduction using a flared stent graft. J Vasc Interv Radiol 23(9):1251-1253, 2012. e-Pub 2012. PMID: 22920989.
Invited Articles
- Fang AM, Jackson J, Gregg JR, Chery L, Tang C, Surasi DS, Siddiqui BA, Soroush-Rais-Bahrami, Bathala TK, Chapin BF. Surgical management and considerations for patients with localized high-risk prostate cancer. Curr Treat Options Oncol 25(1):66-83, 2024. e-Pub 2024. PMID: 38212510.
- Sudha Surasi DS, Kalva P, Hwang KP, Bathala TK. Pitfalls in Prostate MR Imaging Interpretation. Radiol Clin North Am 62(1):53-67, 2024. e-Pub 2024. PMID: 37973245.
- Surasi D, Chapin D, Tang C, Ravizzini G, Bathala TK. Imaging and management of prostate cancer. Seminars in Ultrasound CT and MRI 41(2):207-221, 2020. e-Pub 2020. PMID: 32446432.
Review Articles
- Yadav D, Hwang H, Qiao W, Upadhyay R, Chapin BF, Tang C, Aparicio A, Lopez-Olivo MA, Kang SK, Macapinlac HA, Bathala TK, Surasi DS. 18F-fluciclovine versus PSMA PET imaging in primary tumor detection during initial staging of high-risk prostate cancer: A systematic review and meta-analysis. Radiol Imaging Cancer 4(2):e210091, 2022. e-Pub 2022. PMID: 35212559.
- Taher, A, Jensen, CT, Yedururi, S, Surasi, DS, Faria, SC, Bathala, TK, Mujtaba, B, Bhosale, PR, Wagner-Bartak, N, Morani, A. Imaging of neuroendocrine prostatic carcinoma. Cancers 13(22), 2021. e-Pub 2021. PMID: 34830919.
- Ranasinghe W, Shapiro DD, Zhang M, Bathala TK, Navone N, Thompson TC, Broom B, Aparicio A, Tu SM, Tang C, Davis JW, Pisters L, Chapin BF. Optimizing the diagnosis and management of ductal prostate cancer. Nat Rev Urol 18(6):337-358, 2021. e-Pub 2021. PMID: 33824525.
Abstracts
- Tang C Sherry AD, Haymaker C, Bathala TK, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Efstathiou E, Wang J, Pilie P, Reuben A, Kovitz C, Kumar R, Chapin B, Gomez DR, Wistuba I, Corn PG. Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer EXTEND: A multicenter, randomized phase II trial 114(5):1059-1060. e-Pub 2022.
- Andring LM, Abu-Gheida I, Bathala TK, Yoder AK, Manzar GS, Maldonado JA, Frank SJ, Choi S, Nguyen QN, Hoffman K, McGuire SE, Mok H, Aparicio A, Chapin BF, Tang C. Improved survival outcomes after local therapy in men with metastatic and non-metastatic cT4 prostate cancer presenting with obstructive urinary symptoms. International Journal of Radiation Oncology*Biology*Physics 114(3, Supplement 1):e210-e211, 2022. e-Pub 2022.
- Hinchcliff E, Patel A, Fellman B, Westin S, Sood A, Soliman P, Shafer A, Meyer L, Fleming N, Bathala TK, Ganeshan G, Hwu P, Lu K Jazaeri A. Randomized phase II trial of durvalumab, anti-PDL1 and tremelimumab, anti-CTLA4 administered in combination versus sequentially for the treatment of recurrent platinum-resistant non-clear cell ovarian cancer - NCT03026062. Gynecologic Oncology 162, Supplement 1:S39, 2021. e-Pub 2021.
- Wiele AJ, Surasi DS, Rao P, Sircar K, Su X, Bathala TK, Shah AY, Jonasch E, Cataldo VD, Genovese G, Karam JA, Wood CG, Tannir NM, Msaouel P. Efficacy and safety of bevacizumab plus erlotinib in patients with renal medullary carcinoma. Cancers 13(9), 2021. e-Pub 2021. PMID: 33946504.
- Wiele A, Surasi D, Rao P, Sircar K, Bathala TK, Shah A, Jonasch E, Cataldo V, Genovese G, Karam J, Wood C, Tannir N, Msaouel P. The efficacy of bevacizumab plus erlotinib, B+E in patients with renal medullary carcinoma. Journal of Clinical Oncology 39(6), 2021. e-Pub 2021.
- Gregg, J R, Surasi, D S, Childs, A, Moll, N, Ward, J F, Kim, J, Daniel, C R, Logothetis, C, Bathala TK, Davis JW. The association of periprostatic fat and grade group progression in men with localized prostate cancer on active surveillance. Journal of Urology 205(1):122-128, 2021. e-Pub 2021.
- Ranasinghe W, Troncoso P, Kokorovic A, Elsheshtawi M, Zhang M, Aparicio A, Chapin B, Bathala TK. Defining diagnostic criteria for ductal prostate cancer on prostatic MRI. Journal of Clinical Oncology 38(15, supplement), 2020. e-Pub 2020.
- Ranasinghe W, Shapiro D, Reichard C, Eisheshtawi M, Nyame Y, Sundi D, Tosoian H, Wilkins L, Alam R, Achim M, Bathala TK, Tang C, Aparicio A, Navone N, Pisters L, Stephenson A, Klien E, Ross A, Allaf M, Davis J, Chapin B. Outcomes of men with ductal prostate cancer undergoing definitive therapy for localized disease. Journal of Clinical Oncology 38(Issue 6):e1662, 2020. e-Pub 2020.
- Ranasinghe W, Troncoso P, Kokorovic A, Elsheshtawi M, Zhang M, Aparicio A, Chapin B, TK <. Defining diagnostic criteria for ductal prostate cancer on prostatic MRI. Journal of Clinical Oncology 38(15, supplement):e17532, 2020. e-Pub 2020.
- Lim T, Wang J, Frank S, Stafford R, Bruno T, Bathala TK, Mahmood U, Pugh T, Ibbott G, Kudchadker R. SU-E-J-214: MR protocol development to visualize sirius MRI markers in prostate brachytherapy patients for MR-based post-implant dosimetry. American Association of Physicists in Medicine 42(6, Part 10):3314-3315, 2019. e-Pub 2019.
- Boyce D, Bathala TK, Chen A, Kudchadker R, Bruno T, Frank S. Longer preoperative membranous urethral length is associated with GU toxicity after permanent P1 Prostate brachytherapy. Brachytherapy 18(3, Supplement):s76, 2019. e-Pub 2019.
- Thaker N, Pasalic D, Ning MS, Tang C, Anscher MS, Bathala TK, Kudchadker R, Ma J, Venkatesan AM, Wang J, Stafford RJ, Feeley TW, Frank SJ. Defining the value of magnetic resonance imaging-assisted radiosurgery for prostate brachytherapy: a pilot study using time-driven activity-based costing. Brachytherapy 18(3):S80, 2019. e-Pub 2019.
- Duddalwar V, Lerner S, Huang E, Varghese B, King K, Cen S, Hwang D, Altun E, Bathala T, Kennish S, Ibarra Rovira J, Lucchesi F, Muglia VF, Thomas S, Vikram R, Vargas HA, Fevrier-Sullivan B, Kirby J, Jaffe C, Freymann J. Mp32-02 associations between genetic pathways and radiomic metrics in muscle-invasive bladder cancer. The Journal of Urology 201(4S):e441-e442, 2019. e-Pub 2019.
- Lerner S, Duddalwar V, Huang E, Varghese B, King KG, Cen SY, Hwang, D, Altun E, Bathala TK, Kennish S, Ibarra J, Lucchesi F, Muglia VF, Thomas S, Vikram R, Kirby J, Jaffe C, Freymann J. Associations between genetic pathways and radiomic metrics in muscle-invasive bladder cancer. European Urology Supplements 18(1):e636, 2019. e-Pub 2019.
- Lerner SP, Duddalwar V, Huang E, Altun E, Bathala TK, Kennish S, Ibarra J, Lucchesi F, Muglia VF, Thomas S, Vikram R, Vargas HA, Cen SY, Hwang D, King KG, Varghese B, Fevrier-Sullivan B, Kirby J, Jaffe C, Freymann J. Comprehensive radiogenomics analysis of qualitative and quantitative features of cross-sectional imaging in the TCGA project in MIBC. Journal of Clinical Oncology 37(7):482, 2019. e-Pub 2019.
- Sanders J, Frank S, Bathala T, Venkatesan A, Anscher M, Tang C, Bruno T, Wei W, Ma J. Compressed sensing for prostate cancer brachytherapy post-implant magnetic resonance imaging without an endorectal coil. Brachytherapy 17(4):S72-S73, 2018. e-Pub 2018.
- Reichard CA, Gregg JR, Bathala TK, Achim MF, Nguyen ON, Davis JW, Chapin BF. Pd47-08 predictors of organ confined disease in high and very high risk prostate cancer patients staged with mp-mri: implications for selective application of multimodal therapy. The Journal of Urology 199(4):e900, 2018. e-Pub 2018.
- Reichard C, Bathala TK, Gregg J, Aschim M, Kukreja J, Efsathiou E, Davis J, Chapin B. MP11-03 primary tumor response to next generation anti-androgen therapy assessed by pre-post treatment MRI prior to radical prostatectomy. Journal of Urology 199(4S):e127-e128, 2018. e-Pub 2018.
- Reichard C, Gregg J, Bathala TK, Achim M, Davis J, Chapin B. Is expanded radiographic criteria for clinically positive lymph nodes associated with outcome in pathologically node positive prostate cancer?. Journal of Clinical Oncology 36(6 supplement), 2018. e-Pub 2018.
- Farooqi A, Blanchard P, Bruno T, Kudchadker R, Tang C, Wang J, Venkatesan A, Bathala TK, Ma J, Frank S. Early quality of life outcomes and patient satisfaction metrics for MRI-assisted prostate brachytherapy patients. International Journal of Radiation Oncology*Biology*Physics 99(2, Supplement):E230, 2017. e-Pub 2017.
- Sanders J, Frank S, Venkatesan A, Bathala T, Szklaruk J, Blanchard P, Kudchadker R, Ma J. True FISP for single sequence mr-only post-implant dosimetry of prostate brachytherapy. Med Phys, 2017. e-Pub 2017.
- Farooqi A, Blanchard P, Bruno T, Kudchadker RJ, Wang J, Venkatesan A, Bathala T, Ma J, Frank SJ. Early quality of life outcomes for magnetic resonance imaging - assisted prostate brachytherapy patients. Brachy 16(3):S108, 2017. e-Pub 2017.
- Sanders J, Frank S, Bathala TK, Venkatesan A, Kudchadker R, Blanchard P, Martin G, Wang J, Berner P, Bruno T, Ma J. Magnetic resonance imaging-based prostate brachytherapy - imaging with and without an endorectal coil for post-implant quality assurance. Brachy 16(3):S56, 2017. e-Pub 2017.
- Martin G, Pugh T, Mahmood U, Swanson D, Graber W, Lim T, Kudchadker R, Wang, Bruno T, Bathala TK, Blanchard P, Frank S. Are we ready to replace postimplant CT dosimetry? Permanent prostate brachytherapy postimplant MRI dosimetry using positive contrast MRI markers. International Journal of Radiation Oncology*Biology*Physics 96(2, Supplement 1):E280-E281, 2016. e-Pub 2016.
- Blanchard P, Pugh T, Mahmood U, Swanson D, Graber W, Wang J, Bathala T, Lim T, Bruno T, Martin G, Kudchadker R, Frank S. Magnetic resonance imaging simulation for LDR prostate brachytherapy: Can we replace ultrasound with magnetic resonance imaging for treatment planning? Comparison of pre-planning, Day 0 and Day 30 MR dosimetry. Brachy 15(3):S57, 2016. e-Pub 2016.
- Martin GV, Pugh TJ, Mahmood U, Swanson DA, Graber WJ, Wang JW, Bathala T, Lim T, Bruno T, Martin G, Kudchadker RJ, Frank SJ. Are we ready to replace post-implant computed tomography dosimetry? Permanent prostate brachytherapy post-implant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers. Brachy, 2016. e-Pub 2016.
- Blanchard P, Pugh TJ, Mahmood U, Swanson DA, Graber WJ, Wang J, Bathala TK, LimT, Bruno T, Martin GV, Kudchadker RJ, Frank SJ. Magnetic resonance imaging simulation for low dose rate prostate brachytherapy: Can we replace ultrasound with magnetic resonance imaging for treatment planning? Comparison of pre-planning, day 0 and day 30 magnetic resonance dosimetry. Brachy 15(Supplement 1):S57, 2016. e-Pub 2016.
- Thaker NG, Agarwal A, Pugh TJ, Mahmood U, Guzman AB, Incalcaterra JR, Bathala TK, Kaplan RS, Kudchadker R, Bingham J, Das P, Kuban DA, Bucholz TA, Feeley TW, Frank SJ. Quality improvement in prostate brachytherapy using time driven activity based costing. Brachy 93:E503, 2015. e-Pub 2015.
- Lim T, Wang J, Frank S, Stafford R, Bruno T, Bathala TK, Mahmood U, Pugh T, Ibbott G, Kudchadker R. SU-E-J-214: Magnetic resonance protocol development to visualize sirius magnetic resonance imaging markers in prostate brachytherapy patients for MR-based post-implant dosimetry. Med Phys 42(6):3314-3315, 2015. e-Pub 2015. PMID: 26127603.
- Lim T, Kuchadker R, Wang J, Stafford J, Bruno T, Bathala TK, Mahmood U, Pugh T, Ibbott G, Frank S. Initial patient experience with positive contrast MRI markers for low-dose rate prostate brachytherapy. Brachytherapy 14, Supplement 1:S35, 2015. e-Pub 2015.
- Lim T, Wang J, Frank S, Stafford RJ, Bruno TL, Bathala TK, Mahmod U, Pugh T, Ibbott GS, Kudchadker. Magnetic resonance protocol development to visualize sirius magnetic resonance imaging markers in prostate brachytherapy patients for magnetic resonance-based post-implant dosimetry. Med Phys 41(6):99-99, 2015. e-Pub 2015.
- Lim T, Kudchadker RJ, Wang J, Stafford RJ, Bruno TL, Bathala TK, Mahmod U, Pugh T, Ibbott GS. Initial patient experience with positive-contrast magnetic resonance imaging markers for low-dose-rate prostate brachytherapy. Brachy 14(Supplement 1):S35, 2015. e-Pub 2015.
- Lim T, Wang J, Kudchadker R, Stafford R, Bathala TK, Pugh T, Ibbott G, Frank S. Sirius magnetic resonance imaging markers for prostate post-implant assessment: magnetic resonance protocol development. Med Phys 41(6):99, 2014. e-Pub 2014.
- Atkinson B, Kalra S, Wang X, Bathala TK, Perpich J, Cornizar P, Tannir M, Jonasch E. Outcomes associated with sunitinib alternative schedule compared to traditional schedule: a single-center experience. Proceedings of the American Society of Clinical Oncology Annual Meeting 31(15, supplement), 2013. e-Pub 2013.
- Sherry A, Haymaker C, Bathala TK, Lu X, Medina-Rosales M, Marmonti E, Pradeep H, Liu S, Fellman B, Mok H, Choi S, Chun S, Apraicio A, Kovitz C, Surita-Saavedra A, Gmoex D, Reuben A, Wistuba I, Corn P, Tang C. Metastasis-directed therapy priming of peripheral T cells and micrometastatic disease control: multidimensional immunogenomic profiling of oligometastatic prostate cancer in the EXTEND trial. Annual Proceeding of American Society for Radiation Oncology.
- Hwang K, Venkatesan A, Stafford J, Bathala TK. SPAMM tagged EPI acquisition for assessment of geometric distortion caused by an endorectal coil. ISMRM Annual Meeting Proceedings.
- Sherry A, Bathala TK, Lu, X, Medina R, Marina N, Marmonti E, Pradeep H, Suyu L, Fellman B, Mok H, Choi S, Chun S, Aparicio A, Kovitz C, Surita-Saavedra A, Gomez D, Reuben A, Wistuba I, Corn P, Tang C, Haymaker C. EXTEND prostate intermittent + continuous translational. Proceedings of the American Society of Clinical Oncology Annual Meeting.
Book Chapters
- Bathala TK. Vascular Ultrasound. In: Problem Solving in Cardiovascular Radiology. 1. Elsevier, Inc, 2013.
- Menias C, Soto J, Anderson S, Bathala TK. In: Gastrointestinal Imaging Cases. McGraw-Hill Radiology, 2013.
Letters to the Editor
- Senapati, J, Jabbour, EJ, Short, NJ, Jain, N, Haddad, FG, Bathala, TK, Kovalenko, I, Bidikian, A, Ravandi-Kashani, F, Khouri, IF, Kadia, TM, Garris, R, Montalban Bravo, G, Chien, KS, Shpall, E, Kebriaei, P, Kantarjian, HM. Liver elastography for risk-assessment of liver toxicity and risk factors for sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14, 2024.
Patient Reviews
CV information above last modified July 23, 2025